Salicylamide (CAS 65-45-2)

Salicylamide is a synthetic, crystalline organic compound that has found extensive applications in scientific research. This white, odorless powder is soluble in water. Notably, salicylamide serves as a precursor to aspirin and is present in over-the-counter medications, including pain relievers, fever reducers, and anti-inflammatory drugs. Studies have unveiled that salicylamide exhibits inhibitory properties against cyclooxygenase (COX) enzymes, pivotal players in the synthesis of prostaglandins. Additionally, it can thwart the activity of lipoxygenase (LOX) enzymes involved in the synthesis of leukotrienes. Delving into in vivo models encompassing mice, rats, and rabbits, researchers have explored the therapeutic possibilities of salicylamide. Findings reveal its efficacy in reducing inflammation and alleviating joint pain, suggesting potential benefits in treating conditions such as rheumatoid arthritis. In vitro studies have delved into salicylamide′s effects on various fronts. It demonstrates the ability to impede the growth of specific bacteria, such as Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. Additionally, it exhibits growth-inhibitory properties against specific cancer cell lines, including human breast cancer cells and human colon cancer cells.